pool? Microbial colonization during infancy plays a critical role in the education of many immune cell types. Furthermore, mice exposed to normal microbes tend to produce increased numbers of LLEC populations (Beura et al., 2016) , but whether developmental timing has an influence on this increase has yet to be determined. Additionally, are resident memory cells more likely to form from neonatal or adult precursors? Vaccination studies show that lung resident T cell populations form weakly in early life (Zens et al., 2017) , suggesting that adult mice may be the dominant source of resident memory T cells while early life is spent focused on the lymphoid compartment.
The evidence is considerable that the neonatal and infancy periods of life are a unique and critical time for many cells in the immune system. The current work demonstrates that developmental imprinting of the CD8+ T cell pool during this period has long-lasting effects on T cell responses in adult mice. A new study combines detailed biochemical characterization with whole-animal genetics and computational transcriptome data mining to reveal how the LRRC33 milieu molecule imposes an exquisite level of spatial control on TGF-b signaling in the CNS.
A central goal in the cell-signaling field is to understand how a multitude of related ligands can achieve context-specific outcomes using just a few core signal transduction pathways. With its 33 mammalian ligands but more limited number of receptors and signal transduction components, the transforming growth factor b (TGF-b) superfamily exemplifies this conundrum (Weiss and Attisano, 2013) . Response to a given family member varies depending on the complement of transducing factors present in the responding cell and diverse modes of extracellular regulation of TGFb family ligands. Another avenue to confer specificity is for the producing cell to limit the availability of the ligand by packaging it in a locked state. TGF-b signaling in the brain illustrates the complexity problem. TGF-b signaling is important for normal brain homeostasis, plays roles in neuroimmune and damage responses, and has been implicated in degenerative conditions (Colonna and Butovsky, 2017 Qin et al. (2018) uncover a mechanism where TGF-b1, produced by microglia, is under strict molecular control for localization, activation, and downstream signaling of the growth factor. This novel strategy, whereby only the producing cell can receive the signaling molecule after interaction with a partner cell with the key to unlock the ligand, is an extreme type of autocrine signaling and adds to the mechanistic repertoire that cells use to refine extracellular signaling. TGF-b proteins are produced in a latent form that requires activation (Robertson and Rifkin, 2016) . Following proteolytic cleavage, the growth factor and prodomain remain in a stable latent complex, effectively caging the growth factor. The best-characterized and likely ancestral mechanism for releasing the active cytokine involves integrin binding and tension (Robertson and Rifkin, 2013) . Another layer of regulation is conferred by proteins that are covalently linked to the prodomain inside the producing cell. They function to determine the location of the latent complex and can provide resistance against the integrin-generated force. Previously characterized proteins that regulate TGF-b in this fashion include LTBP 1-4, which enable binding to the extracellular matrix (ECM), and GARP, a transmembrane protein that secures the latent complex to the cell surface (Wang et al., 2012) . Qin et al. (2018) noted homology between GARP (also called LRRC32) and LRRC33 (Su et al., 2014 ) (also called NRROS; Wong et al., 2017) . Expression of LRRC33 and TGF-b1 is positively correlated across many murine and human cell types. In cell culture, proTGFb1 and LRRC33 physically interacted, causing the large latent complex to remain cell associated. In the absence of LRRC33, or upon mutation of two cysteine residues predicted to covalent link to the prodomain, proTGF-b1 is secreted into the culture medium. In a cell line that expresses LRRC33, TGFb1, and subunits for integrin aVb8, the authors find that all these players are required to produce active ligand. The current work thus adds LRRC33 to the list of covalently attached modifiers of proTGF-b and shows that it can function analogously to GARP in retaining latent TGF-b at the surface of the producing cell. The authors further suggest the descriptive term ''milieu molecules'' to highlight their influence on the localization of latent TGF-b and participation in the integrin-mediated activation step.
Importantly, Qin et al. (2018) examined the relationship between LRRC33 and TGF-b1 in vivo using a mouse model lacking LRRC33. LRRC33 mutants develop to adulthood but exhibit progressive neurological symptoms. Histological examination revealed demyelination and degeneration of axons required for motor function. Motivated by expression data and prior links between TGF-b signaling and microglia, the authors probed the status of TGF-b signaling in microglia to explore the cellular genesis of this pathology. Indeed, microglia in the brains of mutant mice show molecular and morphological signs of a reactive phenotype. Peripheral macrophages are also altered in LRRC33 mutants but are likely not connected to the neurodegeneration. To determine if TGF-b signaling is disrupted in LRRC33 mutants, Qin et al. (2018) isolated microglia from LRRC33 mutant mice and carried out gene expression analysis. Previous work found significant changes in microglia gene expression in a mouse model lacking TGF-b1 in the CNS (Butovsky et al., 2014) . The up-and downregulated genes show remarkable concordance with the TGF-b1 mutant dataset, showing that for this cell type, the signal response is entirely dependent In normal microglia (shown to the left), LRRC33 is covalently linked to the prodomain of TGF-b1 during maturation, which in turn holds the growth factor dimer in a latent non-covalent complex. Activation is achieved upon integrin aVb8 from a neighboring cell binding to the prodomain and exerting force to release the mature TGF-b1. The release of the ligand is thus highly localized and available to the participating cells to bind to receptors (represented by ''TGFbR'') to initiate canonical signaling via P-Smad2. In the inset, autocrine signaling is depicted with a square tip, and paracrine signaling is depicted with a round tip. We suggest that additional mechanisms may further control which cell binds the ligand or loads the ligand into receptor complexes. In microglia missing LRRC33 (shown to the right), proTGF-b is not retained at the cell surface and may be secreted. It is therefore not available for localized activation and signaling. At the cellular level, LRRC33-deficient microglia express markers and have morphology indicative of reactive cells. At the animal level, this leads to progressive loss of motoneuron axons and progressive neurodegenerative phenotypes.
on the milieu molecule that positions the latent ligand. Whole-animal TGF-b1 and integrin aVb8 mutants additionally have vascular defects not found in LRRC33 mutants (Aluwihare et al., 2009 ), meaning LRRC33 is required for proper TGF-b signaling only in the subset of CNS cells where it is produced. Other milieu molecules likely facilitate latent TGF-b activation by integrins in other contexts, but this remains to be shown in vivo. Taken together, the phenotypes and gene expression changes indicate that LRRC33 is required for autocrine TGF-b signaling in microglia, which is in turn required for homeostasis in the CNS.
Bone marrow transplants between mice of different LRRC33 genotypes were also performed to determine if wild-type (WT) cells can rescue the pathology of deficient hosts and to explore how microglia of different genotypes influence each other. LRRC33
À/À hosts were healthier if they received transplants of WT bone marrow. Assessing the reactive status of WT and mutant microglia by fluorescence-activated cell sorting (FACS) analysis revealed that transplantderived WT cells do not alter the reactive status of mutant cells. This result invites the remarkable conclusion that TGF-b produced by an individual microglia cell is designated to activate TGF-b receptors on the same cell, but not other microglia. This is an extreme version of autocrine signaling and a surprising case where ligand production behaves cell autonomously (Figure 1 ). In summary, bone marrow transplantation experiments and characterization of the reactive status of WT and LRRC33 À/À microglia supports the inference of a very short TGF-b signaling range. What is the purpose of the LRRC33 scheme to control the locale and recipient of a cytokine? In one view, the producing cell is acting selfishly to ensure that it, or its collaborating integrin-bearing partner, receives the active ligand. If the signal imparted robustness, then such covetous competition would be sensible. Another view is suggested by the surveillance function of microglia. Individual cells monitor their environment and assume different morphologies and activity states in response to conditions such as contact with astrocytes and other integrin-bearing cells. If contact is lost-or not detected, in the case of failure of the LRRC33-proTGF-b system-then a pro-inflammatory response is generated. In this view, the short range of TGF-b serves to appropriately constrain the range of microglia reaction.
The model of finely localized signaling is based on the consequences of signal reception. As imaging technology improves, we could ideally observe the cell-surface events that produce active ligands to study how the range of action is restricted. A trivial explanation is that a ligand is more likely to bind receptors near its release position. This would hold if the ligand was secreted into the extracellular space, but release from latency would be much faster than de novo ligand expression. Alternatively, the LRRC33 plus integrin activation configuration offers additional control. For example, an extended interface between the pro-TGF-b-presenting cell and the integrin-bearing cell could trap the released growth factor to stymie diffusion. Another possibility is that the receptor is positioned near the activation site to efficiently receive a handoff of the growth factor, giving the producing cell an additional level of control to ensure it receives the bulk of the unlocked treasure.
